Fact Sheet: Hydrogen Peroxide (microbicide) INAD 11-669

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:
Hydrogen Peroxide

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet (MSDS)

What's the status of this drug's

Study Summaries

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness and safety of hydrogen peroxide to control mortality caused by ectoparasites in a variety of fish species.
Drug name: 35% PEROX-AID® (hydrogen peroxide)
Source of drug:

Western Chemical Inc.

1269 Lattimore Road
Ferndale, WA 98248 USA

Attention:Jason Montgomery
Toll Free: 800-283-5292 ext 4175
Tel: 360-312-4175
email: jasonm@wchemical.com
webpage: http://www.wchemical.com/

Target pathogen(s): Ectoparasites of the genera Ambiphrya, Chilodonella, Dactylogyrus, Epistylis, Gyrodactylus, Ichthyobodo, Ichthyophthirius, Trichodina, Trichophrya, Argulus, Salmincola, Lernaea, and Ergasilus in freshwater fish species; and of the genera Neobenedenia, Amyloodinium, Cryptocaryon, and Uronema in marine fish species.
Method of administration: Immersion bath
Treatment dosage: Option A: 100 or 150mg/L
Option B: 50, 75 or 100mg/L
Option C: 200mg/L
Treatment regimen:

Option A: Treatment duration is 30 min; 3 consecutive or alternate days
Option B: Treatment duration is 60 min; 3 consecutive or alternate days
Option C: Treatment duration is 30 min; 3 consecutive or alternate days

Withdrawal period:

None. Fish may be allowed to enter the food chain immediately after treatment.

Required test parameters: Investigator must collect mortality data throughout the 5 day pretreatment, treatment, and 10 day posttreatment periods. Investigator should also report general fish behavior and any possible adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 11-669 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

email: bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.